Evotec SE, DE0005664809

Evotec stock pre-market at EUR 3.13: plus 0.32 percent

Published on 10/01/2026 at 08:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evotec stock is at EUR 3.13 pre-market at 8:18 a.m. CEST on October 1, 2026, up plus 0.32 percent versus the EUR 3.12 Lang & Schwarz prior close. Evotec announced a science-chief transition on September 29.

Fotorealistisches Pharma-Labor mit Wissenschaftlern bei Wirkstoffscreening in moderner Biotech-Anlage
Fotorealistisches Pharma-Labor symbolisiert Wirkstoffforschung von Evotec SE, ISIN DE0005664809, moderner Biotech-Standort Hamburg, Illustration mit AI erstellt.

Evotec stock is at EUR 3.13 pre-market at 8:18 a.m. CEST on October 1, 2026, up plus 0.32 percent versus the EUR 3.12 Lang & Schwarz prior close on September 30, 2026.

Evotec stock before the Xetra open

The Lang & Schwarz price was EUR 3.13 at 8:18 a.m. CEST, compared with a prior close of EUR 3.12 on September 30, 2026. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Evotec stock.

Chief Scientific Officer transition

In a corporate announcement published September 29, 2026, EQS News reported that Evotec SE's Chief Scientific Officer, Dr. Cord Dohrmann, would step down effective September 30, 2026. The company said the decision was made by mutual consent.

Evotec said Dohrmann had served as Chief Scientific Officer and a member of the Management Board since 2010. The search for his successor was ongoing, according to the announcement from EQS News.

Disclaimer...

en | DE0005664809 | EVOTEC SE | boerse | 70208290 | bgmi